Speech & Language Pathology

When a catastrophic accident or disease process affects one's ability to speak, it can be an immensely frustrating period of adaptation and recovery. Level Eleven's speech therapy program addresses speech deficits through intensive interventions, but also through gaining a deeper understanding of our patients and their lives. The more we learn about our patients, the better we can apply our therapeutic strategies throughout their entire day...not just their time in the clinic.

LSVT Loud

LSVT LOUD® is an effective speech treatment for individuals with Parkinson disease (PD) and other neurological conditions.  LSVT LOUD, named for Mrs. Lee Silverman (Lee Silverman Voice Treatment – LSVT) was developed in 1987 and has been scientifically studied for nearly 20 years with funding support from the National Institute for Deafness and other Communication Disorders (NIDCD) of the National Institutes of Health. Published research data support improvements in vocal loudness, intonation, and voice quality for individuals with PD who received LSVT LOUD, with improvements maintained up to two years after treatment. Recent research studies have also documented the effectiveness of this therapy in improving the common problems of disordered articulation, diminished facial expression and impaired swallowing. Additionally, two brain imaging studies have documented evidence of positive changes in the brain following administration of the therapy. 

Copied from LSVT Global. Click here for more information

 

 

 

Level Eleven has been pivotal to my husband’s constant recovery! We are so grateful.
— Danielle Hawkins
fullsizeoutput_1b07.jpeg

Published research data support improvements in vocal loudness, intonation, and voice quality for individuals with PD who received LSVT LOUD, with improvements maintained up to two years after treatment. Recent research studies have also documented the effectiveness of this therapy in improving the common problems of disordered articulation, diminished facial expression and impaired swallowing. Additionally, two brain imaging studies have documented evidence of positive changes in the brain following administration of the therapy. 

Copied from LSVT Global. Click here for more information